Table 1.
Clinical features of the normal donors and pediatric acute lymphoblastic leukemia patients.
| NBM/ITP | Pediatric ALL | ||
|---|---|---|---|
| Age | 4.3 (0.7–13.6) | 5.1 (0.9–13.6) | |
| Sex (M/F) | 12/8 | 19/11 | |
| White blood cells (109/L) | 8.4 (3.82–16.97) | 56.9 (2.1–638) | |
| Hemoglobin (g/L) | 129 (90–157) | 81.2 (28–126) | |
| Platelet count (109/L) | 313 (17–498) | 49 (8–195) | |
| Immunophenotyping | B-ALL | ns | 28 |
| T-ALL | ns | 2 | |
| Risk stratification | Standard | ns | 6 |
| Median | ns | 8 | |
| High | ns | 16 | |
| Karyotype | Normal | ns | 18 |
| Abnormal | ns | 12 | |
| Fusion gene | MLL | ns | 2 |
| TEL/AML1 | ns | 7 | |
| BCR/ABL1 | ns | 1 | |
| E2A/PBX | ns | 1 | |
NBM, Normal Bone Marrow; IPT, Idiopathic Thrombocytopenic Purpura; B-ALL, B cell acute lymphoblastic leukemia; T-ALL, T cell acute lymphoblastic leukemia